Medtechchronicles
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
Medtechchronicles
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices
Industry Insights

Amanat Holdings Completes Full Acquisition of Cambridge Health Group

Olivia Brown
Last updated: June 22, 2026 9:18 am
By
Olivia Brown
Share
3 Min Read
Amanat Holdings Cambridge Health Group acquisition
Medtechchronicles
SHARE

A healthcare investment that started several years ago has now reached an important milestone. Amanat Holdings has completed the acquisition of the remaining minority stake in Cambridge Health Group (CHG), giving the Dubai-based investment company full ownership of one of the Gulf region’s leading post-acute care healthcare providers.

Contents
Amanat Secures 100% OwnershipA Leading Post-Acute Care ProviderStrong Financial PerformanceFocus on Future Growth

The transaction marks another step in Amanat’s strategy to strengthen its healthcare portfolio and expand its presence in specialized healthcare services across the GCC.

Amanat Secures 100% Ownership

According to the company, Amanat acquired the remaining 10.03% stake in Cambridge Health Group for AED 105 million. Following the completion of the deal, Amanat now owns 100% of CHG.

The acquisition comes shortly after Amanat increased its stake in the healthcare group to approximately 90% earlier in June 2026. With the latest purchase completed, the company has consolidated full control of the business.

Amanat stated that the transaction reflects its confidence in CHG’s long-term growth potential and its position within the regional healthcare market.

A Leading Post-Acute Care Provider

Cambridge Health Group operates a network of healthcare facilities across the United Arab Emirates and Saudi Arabia. The company focuses on post-acute care services, including long-term care, rehabilitation, specialized medical support, and home healthcare.

According to company information, CHG currently operates around 715 beds and employs more than 1,200 healthcare professionals across its facilities.

The healthcare provider serves patients who require continued medical care and rehabilitation after hospital treatment, making it an important part of the healthcare ecosystem in the region.

Strong Financial Performance

Amanat highlighted CHG’s financial performance as a key factor supporting the acquisition. The healthcare group reported revenue of AED 404 million for the financial year ended December 2025.

During the same period, CHG generated EBITDA of AED 100 million, reflecting continued demand for its healthcare services and operational scale.

The company has expanded steadily in recent years as healthcare systems across the GCC place greater emphasis on rehabilitation, long-term care, and specialized recovery services.

Focus on Future Growth

With full ownership now secured, Amanat plans to continue supporting CHG’s expansion strategy. The company has previously outlined plans to increase the healthcare group’s capacity to more than 1,000 beds in the coming years.

The acquisition gives Amanat greater flexibility in executing long-term growth initiatives while strengthening its position in the region’s healthcare sector.

As demand for specialized healthcare services continues to rise across the GCC, Amanat’s full acquisition of Cambridge Health Group represents a significant step in its efforts to build a larger and more integrated healthcare platform in the region.

Olivia Brown
+ postsBio ⮌
    This author does not have any more posts
TAGGED:Merger & Acquisition
Share This Article
Facebook Copy Link Print
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Samsung Biologics to Acquire PolyPeptide in $1.8 Billion All-Cash Deal

The demand for peptide-based medicines is growing rapidly around the world, and…

David Veino: Leading Neuros Medical’s Bioelectric Revolution in Amputee Care

Imagine surviving the severe physical and emotional trauma of losing a limb,…

Inside Phantom Neuro: How Dr. Connor Glass is Revolutionizing the Muscle-Machine Interface

A Radical Shift in Bionic Evolution For decades, the concept of a…

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.
Sign Up for Free

You Might Also Like

Septa Pharmaceuticals Devinder K. Sethi
Industry Insights

Septa Pharmaceuticals Acquires CeeNU to Strengthen Cancer Care Portfolio

By
Olivia Brown
Wonderdog Secures $5 Million
Industry Insights

Wonderdog Secures $5 Million in Pre-Seed Funding to Expand AI-Powered Canine Health Platform

By
Olivia Brown
RapidPulse Series B Funding
Industry Insights

RapidPulse Raises $48M to Advance Stroke Treatment Technology

By
Olivia Brown
Mykare AI raises $3.2 million
Industry Insights

Mykare AI Raises $3.2 Million to Expand AI Healthcare Platform

By
Olivia Brown
Twitter Linkedin
Company
  • Newsletter
  • News & Perspective
More Info
  • Home
  • Industry Insights
  • Future Of Healthtech
  • Digital Health
  • Women In Medtech
  • Medical Devices

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

Made by Adaptica Solutions For THE HEALTH CHRONICLES

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?